Jilin Xidian Pharmaceutical Technology Development Co., Ltd
Initial public offering and listing on GEM
Announcement of offline preliminary placement results
Sponsor (lead underwriter): Haitong Securities Company Limited(600837)
hot tip
The application of Jilin Xidian Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as “Xidian pharmaceutical” or “the issuer”) for the initial public offering of 2020.0986 million ordinary shares (A shares) (hereinafter referred to as “this offering”) has been approved by the GEM Listing Committee of Shenzhen Stock Exchange, And registered by the China Securities Regulatory Commission (zjxk [2022] No. 5).
Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) ” or “sponsor (lead underwriter)”) serves as the sponsor (lead underwriter) of this offering. The issuer negotiated with the recommendation institution (lead underwriter) to determine the issue price of 22.55 yuan / share.
The issuing price of this offering shall not exceed the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, whichever is lower.
According to the issuing price, the relevant subsidiaries of the sponsor will not participate in the strategic placement. Finally, this issuance will not be targeted to strategic investors. The difference between the initial number of strategic placements and the final number of strategic placements was 1010049 shares, which were transferred back to offline issuance.
This issuance is finally carried out by a combination of offline inquiry and placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-share shares in Shenzhen market and the market value of non restricted Depositary Receipts (hereinafter referred to as “online issuance”).
Before the launch of the online and offline call back mechanism and after the strategic placement call back, the initial offline issuance was 14443986 shares, accounting for 71.50% of the issuance after deducting the final strategic placement; The initial number of shares issued online was 5.757 million, accounting for 28.50% of the number issued after deducting the final strategic placement.
According to the callback mechanism announced in the announcement of Jilin West Point Pharmaceutical Technology Development Co., Ltd. on initial public offering and listing on the gem (hereinafter referred to as the “issuance announcement”), since the initial effective subscription multiple on the Internet is 10064.53743 times, higher than 100 times, the issuer and the recommendation institution (lead underwriter) decided to start the callback mechanism, After deducting the final strategic placement, 20% (4040500 shares) of the number of publicly issued shares will be transferred back from offline to online. After the call back, the final number of offline shares issued was 1040348600, accounting for 51.50% of the number issued after deducting the final strategic placement; The final number of shares issued online was 9.7975 million, accounting for 48.50% of the number issued after deducting the final strategic placement. After the call back, the winning rate of this online pricing issuance is 0.0169092842%, and the subscription multiple is 5913.91090 times.
Please pay attention to the payment link of this offering and fulfill the payment obligation in time on February 16, 2022 (T + 2). The details are as follows:
1. Offline investors shall, in accordance with the announcement on the results of offline preliminary placement of Jilin West Point Pharmaceutical Technology Development Co., Ltd. in its initial public offering and listing on the gem, timely and fully pay the subscription funds for new shares according to the final issuance price and preliminary placement quantity before 16:00 on February 16 (t + 2) 2022.
The subscription funds shall be paid in full within the specified time. If the subscription funds are not paid in full within the specified time or as required, all the new shares allocated to the placing object shall be invalid. If the above circumstances occur when multiple new shares are issued on the same day, all the new shares allocated to the placing object are invalid. If different placing objects share bank accounts, if the subscription funds are insufficient, all the new shares allocated to the placing objects sharing bank accounts will be invalid. Offline investors are allocated multiple new shares on the same day. Please pay for each new share separately.
The shares that offline investors give up to subscribe for are underwritten by the sponsor (lead underwriter).
2. Among the stocks issued this time, the stocks issued online have no circulation restrictions and limited sales period arrangements, and can be circulated from the date when the stocks issued this time are listed on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are unlocked and can be circulated from the date when the shares issued this time are listed and traded on the Shenzhen Stock Exchange; The lock-in period of 10% of the shares is 6 months, and the lock-in period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the lock-in period arrangement for the placement object under their management. Once the quotation is made, it is deemed to accept the offline lock-in period arrangement disclosed in this announcement.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investor who provides effective quotation fails to participate in the subscription or the offline investor who obtains the preliminary placement fails to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The recommendation institution (lead underwriter) shall report the breach of contract to the China Securities Association for the record. The number of violations of placing objects in the stock markets of Beijing stock exchange (hereinafter referred to as “Beijing stock exchange”), Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”) and Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”) shall be calculated together. During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of relevant projects in all sectors of the stock market of Beijing stock exchange, Shanghai Stock Exchange and Shenzhen Stock Exchange.
5. Once this announcement is published, it shall be deemed to have served the notice of allocated payment to the offline investors participating in the offline subscription.
1、 Final result of strategic placement
The offering price is not higher than the lower of the median and weighted average of offline investors’ quotations after excluding the highest quotation, and the median and weighted average of public funds, pensions, social security funds, enterprise annuity funds and insurance funds after excluding the highest quotation. Therefore, the relevant subsidiaries of the sponsor need not participate in the follow-up investment.
This offering does not arrange strategic placement to other investors. Finally, this issuance will not be targeted to strategic investors.
2、 Offline issuance and subscription and preliminary placement results
(I) offline issuance and subscription
According to the measures for the administration of securities issuance and underwriting (CSRC order [No. 144]), the special provisions on the issuance and underwriting of initial public offerings on the gem (CSRC announcement [2021] No. 21), the implementation rules for the issuance and underwriting of initial public offerings on the gem of Shenzhen Stock exchange (revised in 2021) (SZS [2021] No. 919) Detailed rules for the implementation of offline issuance of initial public offerings in Shenzhen market (revised in 2020) (SZS [2020] No. 483), code for underwriting of initial public offerings under the registration system (zsxf [2021] No. 213), detailed rules for the management of offline investors in initial public offerings (zsxf [2018] No. 142) The sponsor (lead underwriter) has verified and confirmed the qualification of investors participating in offline subscription in accordance with the relevant provisions of the rules for the administration of offline investors in initial public offering under the registration system (Zhong Zheng Xie Fa [2021] No. 212).
According to the effective subscription results finally received by the offline issuance electronic platform of Shenzhen Stock Exchange, the sponsor (lead underwriter) makes the following statistics:
The offline subscription of this offering has been completed on February 14, 2022 (t day). After verification, it is confirmed that the 6926 effective quotation placement objects managed by 307 offline investors disclosed in the issuance announcement have all made offline subscription in accordance with the requirements of the issuance announcement, and the effective subscription quantity is 46021.8 million shares. (II) preliminary offline placement results
According to the preliminary announcement of Jilin Provincial Science and Technology Co., Ltd. (hereinafter referred to as the “IPO principle”) and the initial public offering method of the underwriter of China Pharmaceutical (hereinafter referred to as the “IPO” of Jilin Provincial Science and Technology Co., Ltd. “, the underwriter recommended and recommended the initial public offering method of China Pharmaceutical (hereinafter referred to as the” gem “), The effective subscription and preliminary placement of various offline investors are shown in the table below:
The effective subscription shares of the placement object account for the total effective subscription shares, and the initial placement shares account for the final issuance of various investors offline
Proportion of purchase quantity (10000 shares) proportion of purchase quantity (shares) proportion of line quantity placing proportion
Class a investors 2181250 47.40% 7387824 71.01% 0.03386968%
Class B investors 13300 0.29% 30058 0.29% 0.02260000%
Class C investors 2407630 52.31% 2985604 28.70% 0.01240059%
Total 4602180 100.00% 10403486 100.00%-
Note: if the total number is inconsistent with the mantissa of the sum of the sub item values, it is caused by rounding.
Among them, the remaining 2768 shares were placed to ” Boc International (China) Co.Ltd(601696) ” managed by ” Boc International (China) Co.Ltd(601696) ” in accordance with the offline placement principle in the preliminary inquiry and promotion announcement “.
The above placement arrangements and results comply with the placement principles published in the preliminary inquiry and promotion announcement. See “attached table: preliminary placement list of offline investors” for the allocation of each placement object.
3、 Contact information of sponsor (lead underwriter)
If offline investors have any questions about the offline preliminary placement results announced in this announcement, please contact the sponsor (lead underwriter) of this offering. The specific contact information is as follows:
Sponsor (lead underwriter): Haitong Securities Company Limited(600837)
Tel: 021-23219622, 021-23219496, 021-23219524, 021-23219904 contact: capital market department
Issuer: sponsor (lead underwriter) of Jilin West Point Pharmaceutical Technology Development Co., Ltd.: Haitong Securities Company Limited(600837) February 16, 2022 (no text on this page) (seal page of the announcement on the results of initial public offering and offline preliminary placement of Jilin Xidian Pharmaceutical Technology Development Co., Ltd. listed on the GEM)
Issuer: Jilin West Point pharmaceutical science and Technology Development Co., Ltd. (this page has no text, which is the seal page of the announcement on the results of initial public offering and offline preliminary placement of Jilin West Point pharmaceutical science and Technology Development Co., Ltd. listed on the GEM)
Sponsor (lead underwriter): Haitong Securities Company Limited(600837) schedule: preliminary placement details of offline investors
Serial number name of investor name of placing object name of securities account effective subscription quantity of initial allotment type of shares (10000 shares / 10000 shares) (share) amount (yuan)
1 YONGYING Fund Management Co., Ltd. YONGYING Huitianli flexible allocation hybrid securities investment 0899166748 700 2370 53443.50 a-fund
2 YONGYING Fund Management Co., Ltd. YONGYING consumption theme flexible allocation hybrid securities 0899180350 700 2370 53443.50 a investment fund
3. YONGYING intelligent leading hybrid securities investment fund of YONGYING Fund Management Co., Ltd. 0899181815 700 2370 53443.50 a
4 YONGYING Fund Management Co., Ltd. YONGYING Huize regularly opens and flexibly allocates a hybrid 0899195085 700 2370 53443.50 A-type sponsored securities investment fund for one year
5. YONGYING Fund Management Co., Ltd. YONGYING CSI 300 index sponsored securities investment 0899198907 700
